Document Detail


Susceptibility to phorbol ester skin tumor promotion in (C57BL/6 x DBA/2) F1 mice is inherited as an incomplete dominant trait: evidence for multi-locus involvement.
MedLine Citation:
PMID:  3128409     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Since current evidence suggests that the tumor promotion stage is a primary determinant in susceptibility to multistage carcinogenesis, we have characterized the genetics of susceptibility to phorbol ester skin tumor promotion in inbred mice. Susceptibility of hybrids (B6D2F1), between DBA/2 (sensitive) and C57BL/6 (resistant) parents, initiated with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and promoted with 12-O-tetradecanoylphorbol-13-acetate (TPA) was similar to DBA/2 mice at doses of 13.6 nmol per mouse but clearly less when doses of 1.7-6.8 nmol per mouse were used. In addition, no significant differences were observed between male and female B6D2F1 mice in terms of tumor incidence although some differences were observed in tumor multiplicities between male and female F1 mice at the highest TPA dose. Reciprocal F1 mice initiated with DMBA (i.e. D2B6F1) were also responsive to TPA. Female D2B6F1 mice were of lower sensitivity at lower doses of TPA, compared to female DBA/2, a finding similar to that observed with B6D2F1 mice initiated with MNNG. Further analyses of the susceptibility of B6D2F2 and B6D2F1 X C57BL/6 backcross mice to TPA promotion indicated that more than one dominant genetic locus must account for the differences in promotion sensitivity between DBA/2 and C57BL/6 mice. To understand further the genes responsible for promotion sensitivity, histological evaluations were performed on DBA/2, C57BL/6 and B6D2F1 mice. Histological examination revealed that the epidermis of DBA/2 mice showed a marked hyperplasia and the presence of a much greater number of dark basal keratinocytes (DCs) compared with C57BL/6 mice 48 h after the last of four applications of TPA (doses greater than or equal to 3.4 nmol). A marked dermal infiltration of polymorphonuclear leukocytes (PMNs) was observed in DBA/2 mice, whereas little infiltration was observed in the skin of C57BL/6 mice. The hyperplasia in the skin of B6D2F1 mice was intermediate between DBA/2 and C57BL/6 mice at all TPA doses examined except the lowest dose (1.7 nmol), whereas the DC response, although significantly lower at doses of 6.8 nmol or below, was similar to DBA/2 mice at higher TPA doses (13.6 and 17.0 nmol). The infiltration of PMNs in the dermis of B6D2F1 mice was similar to or greater than DBA/2 mice at all doses of TPA tested.(ABSTRACT TRUNCATED AT 400 WORDS)
Authors:
M Naito; K J Chenicek; Y Naito; J DiGiovanni
Related Documents :
17525259 - Control of pseudomonas aeruginosa skin infections in mice is mast cell-dependent.
9933619 - Tgf-beta3, but not tgf-beta1, protects keratinocytes against 12-o-tetradecanoylphorbol-...
21641399 - Role of p47phox in antigen-presenting cell-mediated regulation of humoral immunity in m...
1712799 - Experimental cutaneous protothecosis in mice: epithelioid cell granuloma formation.
18648529 - Type i interferon: potential therapeutic target for psoriasis?
18641349 - Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by i...
11838839 - Constitutive expression of angiopoietin-1 and -2 and modulation of their expression by ...
1016219 - Genetic control of heat sensitivity and activity level of murine arylsulfatase b.
8403569 - Increased release of tumor necrosis factor-alpha by monocytes from patients with glomer...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Carcinogenesis     Volume:  9     ISSN:  0143-3334     ISO Abbreviation:  Carcinogenesis     Publication Date:  1988 Apr 
Date Detail:
Created Date:  1988-05-20     Completed Date:  1988-05-20     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8008055     Medline TA:  Carcinogenesis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  639-45     Citation Subset:  IM    
Affiliation:
University of Texas System Cancer Center, Smithville 78957.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
9,10-Dimethyl-1,2-benzanthracene
Animals
Crosses, Genetic
Genes, Dominant*
Male
Methylnitronitrosoguanidine
Mice
Mice, Inbred C57BL / genetics
Mice, Inbred DBA / genetics
Mice, Inbred Strains / genetics*
Skin Neoplasms / chemically induced,  genetics*
Species Specificity
Tetradecanoylphorbol Acetate
Grant Support
ID/Acronym/Agency:
CA 38871/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
16561-29-8/Tetradecanoylphorbol Acetate; 57-97-6/9,10-Dimethyl-1,2-benzanthracene; 70-25-7/Methylnitronitrosoguanidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of 32P-postlabeling and high pressure liquid chromatographic analyses for 7,12-dimethylbe...
Next Document:  Epidermal papillomas and carcinomas induced in uninitiated mouse skin by tumor promoters alone conta...